| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Baupost Group · Seth Klarman | $178.6M | 3.30% | 1.41M | −12% | Q2 2026 |
| Renaissance Technologies | $9.6M | 0.01% | 75.70K | +34% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Lisa McClain MI09 | 1 | 1 | +$0 | Sold Jul 22, 25 |
| Rob Bresnahan PA08 | 1 | −$8.0K | Sold Feb 25, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Jul 22, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Aug 13, 25 (22d) | |
| Jul 16, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (28d) | |
| Feb 25, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | Mar 27, 25 (30d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 7, 2026 | Salmon Sean MDirector | Stock Award(Grant) at price 0.00 per share. | 674 | — |
| Jun 7, 2026 | Randle Stuart ADirector | Stock Award(Grant) at price 0.00 per share. | 5.7K | — |
| Jun 7, 2026 | Weidman Jason R.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 54K | — |
| May 14, 2026 | Krakauer Andrew ADirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| May 14, 2026 | Haggerty Gretchen RDirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| May 14, 2026 | Duncan Candace HDirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| May 14, 2026 | Tokich Michael JosephDirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| May 14, 2026 | Patil Neena MDirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| May 14, 2026 | Ryu JaewonDirector | Stock Award(Grant) at price 0.00 per share. | 1.1K | — |
| Mar 2, 2026 | Hicks Cameron POfficer | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Mar 2, 2026 | Deren JohnChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 13.8K | — |
| Mar 2, 2026 | Winters JamesOfficer | Stock Award(Grant) at price 0.00 per share. | 13K | — |
| Mar 2, 2026 | Logue Daniel V.General Counsel | Stock Award(Grant) at price 0.00 per share. | 9.9K | — |
| Feb 22, 2026 | Hicks Cameron POfficer | Stock Award(Grant) at price 0.00 per share. | 352 | — |
| Feb 22, 2026 | Deren JohnChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 161 | — |
| Feb 22, 2026 | Winters JamesOfficer | Stock Award(Grant) at price 0.00 per share. | 354 | — |
| Feb 22, 2026 | Logue Daniel V.General Counsel | Stock Award(Grant) at price 0.00 per share. | 443 | — |
| Jan 12, 2026 | Randle Stuart AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 12.3K | — |
| Aug 5, 2025 | Haggerty Gretchen RDirector | Purchase at price 114.73 - 114.78 per share. | 500 | $57.38K |
| Aug 4, 2025 | Randle Stuart ADirector | Purchase at price 115.86 per share. | 1K | $115.86K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.5 | 16.9 | -2.0 | 3.6 | 3.8 | -1.5 | 7.8 | 3.9 | -12.0 | -0.4 | +2.0% | ||
| 2025 | 1.3 | -26.3 | 4.1 | -0.8 | -10.8 | -3.2 | 1.0 | 5.8 | -3.2 | 1.7 | -8.1 | 6.7 | −31.4% |
| 2024 | -2.6 | -8.3 | 1.5 | -7.7 | 0.2 | 0.6 | 5.0 | 11.0 | 0.9 | -18.7 | -4.1 | -7.7 | −28.6% |
| 2023 | -2.5 | -2.1 | 6.3 | 7.6 | -13.9 | 3.1 | 3.8 | -15.3 | -7.7 | -5.9 | 22.2 | 10.5 | −0.1% |
| 2022 | -5.6 | 8.4 | 5.5 | -19.5 | 0.7 | -14.6 | -2.2 | -5.9 | -11.0 | 6.5 | 9.1 | 6.6 | −24.0% |
| 2021 | -8.2 | 5.4 | 4.4 | 1.7 | -4.8 | -0.1 | -1.1 | -0.5 | -4.8 | -5.2 | -16.7 | 10.4 | −20.2% |
| 2020 | -1.3 | -9.8 | -12.6 | 14.5 | 8.2 | 0.3 | 2.5 | 5.3 | -13.4 | -6.5 | 20.3 | 7.5 | +9.3% |
| 2019 | 5.8 | 6.0 | 4.3 | -5.3 | 0.7 | 14.9 | 2.6 | 7.1 | -6.6 | 2.3 | 1.7 | 6.5 | +45.6% |
| 2018 | 11.6 | -10.1 | 2.1 | 5.1 | -0.3 | 0.4 | 1.7 | -9.3 | 7.5 | -9.5 | 14.4 | -6.2 | +3.9% |
| 2017 | 4.1 | 14.0 | 1.3 | 6.8 | -3.3 | 3.9 | -0.3 | 2.2 | 14.3 | -2.1 | 12.0 | -6.3 | +54.4% |
| 2016 | 3.2 | 5.3 | 9.9 | -0.8 | 3.4 | 10.1 | 1.7 | 1.5 | -8.2 | -14.8 | 3.4 | 8.9 | +22.6% |
| 2015 | -4.6 | 11.1 | -0.7 | 1.8 | 4.7 | 5.2 | -1.1 | -2.4 | -5.0 | 7.1 | -1.0 | -0.2 | +14.5% |
| 2014 | -0.2 | 8.9 | 5.1 | -4.8 | 4.5 | -1.0 | 2.0 | 1.6 | -4.1 | 8.6 | 4.4 | -3.6 | +22.3% |
| 2013 | 5.2 | 6.6 | 5.7 | -7.5 | 0.3 | -1.1 | 2.5 | -3.0 | 6.7 | 12.0 | 6.7 | -4.5 | +31.6% |
| 2012 | -0.2 | -3.1 | 3.2 | 2.5 | -5.2 | 2.5 | 4.6 | 3.6 | 4.3 | -1.3 | 1.8 | 3.0 | +16.3% |
| 2011 | 6.5 | 1.9 | -0.7 | 8.7 | -1.4 | -1.7 | -1.4 | -4.5 | -6.5 | 11.3 | 1.7 | 0.7 | +13.9% |
| 2010 | 6.1 | 6.6 | 5.1 | -4.3 | -8.5 | -3.2 | 4.4 | -15.2 | 18.1 | -1.8 | -10.4 | 7.7 | −0.1% |
| 2009 | 6.1 | -10.7 | -17.7 | 10.0 | 4.4 | -0.0 | 7.0 | -5.5 | 6.6 | 3.0 | 4.7 | 3.5 | +7.6% |
| 2008 | -6.2 | -4.3 | -15.6 | 15.5 | 7.6 | -6.2 | 10.3 | 5.3 | -1.7 | -16.5 | -10.6 | 5.7 | −20.5% |
| 2007 | 3.4 | 0.2 | 1.7 | 5.5 | 11.8 | 1.8 | -6.5 | 1.8 | 0.2 | -6.0 | -17.6 | 4.4 | −2.4% |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Buy / hold / sell counts